Cart
sales@molnova.com
MN-25
CAS No. 501926-82-5
MN-25( MN 25 | AR-12 | AR 12 )
Catalog No. M14692 CAS No. 501926-82-5
A potent, reasonably selective agonist of peripheral cannabinoid receptor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMN-25
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, reasonably selective agonist of peripheral cannabinoid receptor.
-
DescriptionA potent, reasonably selective agonist of peripheral cannabinoid receptor with Ki of 11 nM for CB2, 22-fold selectivity over the psychoactive CB1 receptors (Ki=245 nM).
-
In Vitro——
-
In Vivo——
-
SynonymsMN 25 | AR-12 | AR 12
-
PathwayGPCR/G Protein
-
TargetCannabinoid Receptor
-
RecptorCannabinoid Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number501926-82-5
-
Formula Weight439.59
-
Molecular FormulaC26H37N3O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC1(C2CCC(C2)(C1NC(=O)C3=CN(C4=C3C=CC=C4OC)CCN5CCOCC5)C)C
-
Chemical NameN-[(S)-Fenchyl]-1-[2-(morpholin-4-yl)ethyl]-7-methoxyindole-3-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Wrobleski ST, et al. J Med Chem. 2003 May 22;46(11):2110-6.
2. Hynes J Jr, et al. Bioorg Med Chem Lett. 2002 Sep 2;12(17):2399-402.
molnova catalog
related products
-
JTE907
A potent, selective, orally active cannabinoid CB2 receptor inverse agonist with Ki of 35.9, 1.55 and 0.38 nM for human, mouse and rat CB2, respectively.
-
CB2R PAM
CB2R PAM is an orally active cannabinoid type 2 receptor (CB2Rs) positive allosteric modulator that enhances CP 55940 and 2-Arachidonylglycerol-stimulated [35S]GTPγS binding to CB2 receptors without affecting receptor activity in the absence of agonists.
-
EHP-101
VCE-004.8 is a specific dual agonist of PPARγ and CB2 receptor with potent anti-inflammatory activity. VCE-004.8 attenuates adipogenesis and prevents diet-induced obesity.
